Job and Career

For more than a century, SSI's main task has been to secure the preparedness towards infectious diseases and congenital disorders.

Today, SSI is an international research and service enterprise employing approx. 800 employees.

Do you want to be a part of a company that makes a difference?

Read more about working at SSI

R and DSSI is one of Denmark’s largest research institutions in the health sector
Contract ServicesSSI provides contract work within our core activities and competences
Job and CareerRead about SSI as a workplace and meet some of our employees
EPI-NEWSNational surveillance of communicable diseases
Girl in the rain

New mission and strategy

SSI has produced a new strategy with a focus on infectious disease preparedness, biobanking and biomarkers, and research. Read more about SSI's new strategy...
Danish National Biobank

The Danish National Biobank

The Danish National Biobank gives scientists from Denmark and abroad overview and access to more than 16 million biological samples in both existing and future collections. Read more about the Danish National Biobank...
Statens Serum Institut (SSI) in Copenhagen Denmark has been granted a sum of EUR 13.8 million from the European & Developing Co...
The disease outbreak now counts 27 patients who have been affected by infectious inflammation of the liver caused by hepatitis...
Since 2010, the number of Danes who were vaccinated abroad following possible exposure to rabies has doubled.

More news...

Hepatitis A virus outbreak due to Iranian dates
Hepatitis B, acute and chronic 2017
Boys who feel attracted to boys are not eligible for free HPV vaccination at their GP
Rabies 2016 and 2017 and new recommendations for rabies prophylaxis
Individually notified diseases 2017
Adaptation to the Danish childhood vaccination programme
Recommendations for tetanus prop...
New contents and publication frequency for EPI-NEWS
Updated advice on vaccination of children before travels

More EPI-NEWS...

Statens Serum Institut (SSI) in Copenhagen Denmark has been granted a sum of EUR 13.8 million from the European & Developing Countries Cl...
Scientists at SSI have developed a new potential vaccine against infections from the enteropathogen, Clostridium difficile (CD).
The number of tuberculosis cases among Swedish and Finnish indigenous citizens falls faster than in Denmark shows a new Nordic survey.
New research from CVIVA shows that Danish children, who have received the live MMR vaccine together with the non-live DTaP-IPV-Hib vaccin...

More R and D News...

Deadline for application: 12-04-2018
About us   Bandim Health Project evaluates the real life effects of health interventions. Past work has documented that health interven...

Read more about working at SSI.